RE:A lot of people give me way too much creditStockguru, based on my recent notes, all the readers were aware that this PP was coming. We just didn't know when and at what price. I was surprised that the SP hit as high as it did. Those that got in at 9-10 cents and sold at .15 made a little coin.
The shoe still has to drop on the CFDA and USFDA approvals before this company can gain important traction. As highlighted before the other prescreening device PREVU has not been a market pleaser so the jury is still out on the SCOUT, even tho the trials and reviews have been very positive. The $90M order with the Chinese is on the table but so was a Letter of Intent with India with PreVu and that went no where. I'm sure the Chinese have an out.
Why haven't the World Health and Cdn Diabetes organizations provided their endorsements? However, will probably pick up additional shares when/if the stock hits the 10-11 cent area. Risk is now lower now that the PP is out there. However, they are capable of another PP so be careful out there.